MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Enliven Therapeutics, Inc. (ELVN)
Enliven Therapeutics, Inc. (ELVN)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$24,343K
Interest income
$4,196K
Net loss
-$23,627K
Net unrealized
gaines on marketable...
-$716K
Total other income
(expense), net
$4,196K
Loss from operations
-$27,823K
Total operating
expenses
$27,823K
Research and development
$20,687K
General and
administrative
$7,136K
Back